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Introduction
Pharmaceuticals are chemical and biological 
substances produced by the pharmaceutical 
industry, used in therapies and prevention of 
various diseases. They cover an extremely 
wide range of products, ranging from simple 
medicinal preparations, to extremely advanced 
technological specifi cs. Similar to food, 
pharmaceutical products are believed to be one 
of the most important needs of human beings. 
They have a signifi cant impact on their health, 
often support and extend their lives. Due to 
their specifi c properties and healthcare function 
of pharmaceuticals, they are contained in the 
category of basic products and their signifi cance 
is appreciated not only by buyers (patients) 
but also by authorities in most countries. That 
is why in many countries special attention 
is paid to the development of production and 
trade in pharmaceutical products. The special 
importance of the pharmaceutical industry was 
also emphasized in a European Commission 
document, which indicated that it is a strategic 
branch of Europe’s industry (European 
Commission, 2014).
The important role of international trade 
in pharmaceutical products is the resultant 
of many factors determining the situation on 
the global pharmaceutical market. The major 
factors include as follows:
 restrictive legal provisions; they concern 
every stage of the production and 
distribution chain, from the synthesis of 
active substances to the dispensing of the 
drug to the patient;
 limited possibility of transferring unique 
technologies within the pharmaceutical 
sector, resulting mainly from huge costs; the 
development and implementation of new 
effective medicines for production is not 
only very costly but also time-consuming;
 patent protection of many pharmaceutical 
products; global pharmaceutical concerns 
effectively protect their production, making it 
impossible for other producers with generic 
equivalents of patented drugs to enter the 
market;
 aging societies and an increase in the 
problem of civilization diseases, especially 
in developed countries and the related 
increase in the demand for medicines and 
medical products.
The largest part of world trade is intra-
industry trade. It occurs when countries 
simultaneously export and import products 
belonging to the same industry branch 
(commodity group). It develops particularly 
well in industrialized countries in the scope 
of processed products, especially those that 
are available in many versions or variants 
(Łapińska, 2016; Cieślik & Wincenciak, 2018). 
This category also includes medicines and 
other products delivered to the market by 
the pharmaceutical industry. Many factors 
determine the commencing and intensity of 
intra-industry trade. The creators of theoretical 
models of intra-industry trade perceive the 
reasons for the development of this type of 
exchange in the existence of a specifi c, usually 
imperfectly competitive market structure, 
where various types of products are traded. 
The nature of the production technique used 
is also signifi cant, characterized by increasing 
economies of scale. However, the diversity of 
products and the presence of economies of 
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scale are only a prerequisite for the emergence 
of intra-industry trade fl ows. A range of factors 
determines whether intra-industry trade 
between countries will be initiated and then 
developed. These factors refl ect the specifi cs 
of trading countries and characteristics of 
markets, products and industries (branches) in 
which the exchange takes place.
The existing subject literature lacks 
empirical fi ndings on the factors determining 
intra-industry trade in pharmaceutical products, 
especially in European Union trade. The few 
publications on the determinants of intra-
industry trade in this extremely important group 
of products concern the Middle East countries 
(see Yusefzadeh et al., 2015; Aghlmand et al., 
2018). Therefore, this study is an attempt to fi ll 
part of the existing research gap in this area.
The purpose of this study is to identify the 
country-specifi c determinants impacting the 
intensity of intra-industry trade within Poland’s 
trade turnover with European Union countries 
in pharmaceutical products.
1. Country-Specifi c Determinants 
of Intra-Industry Trade – Literature 
Review
The specifi city of intra-industry trade means 
that so far it has not been possible to develop 
one model that would explain the existence 
of all streams of this type of exchange. This 
results in some diffi culties in identifying the 
factors determining the development of intra-
industry trade. Individual models (see e.g., 
Krugman, 1979; Brander, 1981; Davis, 1995) 
explain the existence of only some specifi c 
intra-industry trade streams. Depending 
on the adopted assumptions of the model 
construction (e.g., the structure of the market 
on which the exchange is being carried out, 
the type of goods being subject to exchange), 
different conclusions can be drawn as to the 
prospects for the development of two-way 
trade. It causes that the set of determinants 
of intra-industry trade, referring both to the 
characteristics of economies participating in 
the exchange, and to the characteristics of 
industries and products subject to exchange 
is quite wide. Among the researchers of intra-
industry trade, there is, however, a greater 
consensus on macroeconomic determinants 
of the development of intra-industry trade, 
i.e., country-specifi c determinants rather than 
industry-specifi c determinants.
Previous theoretical and empirical studies 
confi rm that the determinant that is conducive 
to the development of intra-industry trade is the 
high level of gross domestic product per capita. 
The impact of GDP per capita on the intensity 
of intra-industry trade can be interpreted in 
two ways ⎼ from the supply and demand sides 
(Czarny, 2002). First of all, highly developed 
economies are characterized by a higher level 
of innovation and have a better developed 
processing industry. This facilitates the 
introduction and development of the production 
of substitute goods with a signifi cant degree 
of differentiation, which, in turn, facilitates the 
development of two-way trade. Secondly, high 
income consumers are more likely to buy 
diversifi ed, highly processed products which, in 
turn, facilitate the development of the exchange 
of similar products belonging to the same 
branch. The importance of high GDP per capita 
in increasing the intensity of intra-industry trade 
is also confi rmed by Thorpe and Zhang (2005), 
Dalgin (2010), Phan and Jeong (2014).
Small differences between GDP per 
capita of trading countries constitute another 
factor supporting the development of intra-
industry trade. They can be indicative of similar 
consumer preferences of buyers from both 
countries. Such an interpretation refers to the 
concept of similarity created by Linder (1961), 
according to which the intensity and structure of 
trade depend mainly on the degree of similarity 
between countries. The importance of this 
determinant in increasing the intensity of intra-
industry exchange is confi rmed by Loertscher 
and Wolter (1980), Thorpe and Zhang (2005), 
Łapińska (2014).
A signifi cant factor determining the 
intensity of intra-industry trade is the size of 
economies that trade with each other. They 
are usually measured by the size of their GDP. 
The size of economies is recognized as a key 
determinant in the development of turnover in 
the gravity models of trade (see, for example, 
Anderson, 1979; Bergstrand, 1985; Pietrzak & 
Łapińska, 2014, 2015; Cieślik & Michałek, 2018; 
Szczepaniak, 2018). The bigger the trading 
partners’ economies, the more intensive trade 
exchange, including intra-industry trade. This is 
confi rmed by numerous empirical studies (see, 
for instance: Caetano & Galego, 2007; Onogwu, 
2013; Jámbor, 2014; Aghlmand et al., 2018).
The size of the economy is related to 
the possibility of developing production 
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characterized by increasing economies of 
scale, which in the light of the theory of intra-
industry trade are one of the key determinants 
encouraging countries to specialize in intra-
industry and two-way trade. The size of GDP 
is also considered to be a measure of the 
development of production of diverse goods 
and an important factor affecting the level of 
international competitiveness of countries 
(Cheba & Szopik-Depczyńska, 2017). Higher 
GDP is then tantamount to having a large 
capital stock and developed fi nancial markets, 
which provide fi nancial support for capital-
intensive, technologically advanced industries 
(Kocmanová, Dohnal, & Meluzín, 2011; Meluzín 
& Zinecker, 2014; Meluzín et al., 2017). This, in 
turn, enables the development of the processing 
industry manufacturing diverse goods.
The factor supporting the development of 
intra-industry trade is also small differences in 
the size of the trading countries’ economies, 
expressed as the differences in the levels of 
GDP of trading partners. This determinant is 
related to Helpman’s theorem (1987), which 
showed that bilateral trade between countries is 
directly proportional to the product of their gross 
domestic products. He confi rmed the truth of 
his claim with reference to highly developed 
countries. Empirical tests of Helpman’s theorem 
were also carried out by other researchers 
(see, for example, Hummels & Levinsohn, 
1995; Okubo, 2007). The results obtained 
by them indicate the existence of a negative 
correlation between intra-industry trade and 
large differences in the size of countries that 
trade with each other. There are, however, 
some empirical studies that do not confi rm 
this relationship. According to Markusen 
and Vanables (1996), comparable sizes of 
economies are not necessarily conducive to 
the development of intra-industry trade. Under 
certain conditions, intra-industry trade may be 
replaced by mutual direct investments (Fukao, 
Ishido, & Ito, 2003; Nazarczuk & Umiński, 
2018).
Other factors determining the level of intra-
industry trade between countries is a large 
share of goods processed in mutual trade and 
a signifi cant intensity of trade contacts between 
trading partners. Ekanayake (2001) and 
Łapińska (2016) show that they signifi cantly 
support the development of intra-industry 
trade. Empirical research (see, for instance, 
Leitão, 2011; Łapińska, 2014) also shows that 
imbalance of trading countries’ trade balance 
has an adverse effect on the intensity of intra-
industry trade. If trade exchange between two 
countries is not balanced, then the intensity of 
intra-industry trade cannot reach the maximum 
value.
A factor signifi cantly affecting the degree 
of intensity of trade between countries is also 
the geographical distance that separates the 
trading partners. A considerable distance 
between two trading countries results in an 
increase in transaction costs, mainly due to 
the cost of transport and insurance of goods. 
It is therefore a factor limiting the development 
of trade, including intra-industry trade (Leitão 
& Shahbaz, 2012; Phan & Jeong, 2014; 
Łapińska, 2016).
The factor supporting the development 
of intra-industry trade related to geographical 
proximity is having a common border with 
a trading partner (Ekanayake, 2001). This 
dependence is mainly due to the possibility of 
using the advantages related to the location 
of production. The intensifi cation of intra-
industry trade is also strengthened by cultural 
community, similar language, historical 
and political ties (Czarny, 2002). However, 
Matthews (1998) argues that these factors lose 
their importance as the economic integration 
progresses.
Intra-industry trade becomes more 
intense where economies begin to open up. 
The most common measure of the protection 
of the internal market in this context is the 
nominal level of customs duties. The negative 
relationship between the size of trade barriers 
and the intensity of intra-industry trade was fi rst 
noticed by Balassa (1966). The existence of 
this dependence was confi rmed later in other 
studies carried out by, for instance, Bergstrand 
(1990), Sharma (2004), Foster and Stehrer 
(2011), and Łapińska (2015). The opening of 
economies is connected with another important 
factor supporting intra-industry trade, namely 
integration processes. The importance of 
economic integration in increasing the intensity 
of intra-industry trade is associated not only 
with the reduction of restrictions on trade but 
is also due to the fact that the integration group 
usually includes countries with a similar level of 
economic development. The results of empirical 
research (see, among others: Sharma, 2004; 
Wakasugi, 2007; Foster & Stehrer, 2011; 
Łapińska, 2015) prove that in the conditions 
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of imperfections of competition and product 
differentiation, integration processes favour the 
development of intra-industry trade.
In empirical studies, attempts are made to 
verify other factors, such as, for example, foreign 
direct investment (Xing, 2007; Ambroziak, 
2016). The impact of FDI on the development 
of intra-industry trade can be positive, providing 
it contributes to the modernization of the 
economy, industrial development and the 
production of diverse goods, or negative, if it is 
a substitute for trade with foreign countries.
2. Intensity of Intra-Industry Trade 
in Pharmaceuticals between 
Poland and European Union 
Countries
In most cases, the Grubel-Lloyd index is used 
in empirical research to measure the intensity 
of intra-industry trade and it is calculated 
according to the following formula (Grubel & 
Lloyd, 1975):
 
(1)
where Xi – the value of exports of the industry i; 
Mi – the value of imports of the industry i.
The above indicator takes values from 
the interval [0;1]. The higher the GLi indicator 
value, the more intense intra-industry trade. The 
maximum value is achieved if the turnover of 
a given industry (branch) is balanced (Xi = Mi); 
Then, the entire trade volume within this branch 
is intra-industry like. If, however, branches do not 
export or import goods at all (Xi = 0 or Mi = 0), the 
GLi index takes the value equal to zero, which 
means that no intra-industry trade occurs. 
Examining the intensity of intra-industry 
trade with a specifi c trading partner requires the 
use of a bilateral index:
 
(2)
where Xij – the value of exports to the country 
of the trading partner j of goods belonging 
to the industry i; Mij – the value of imports to 
the country of the trading partner j of goods 
belonging to the industry i.
An aggregated measure that shows the 
intensity of intra-industry trade in all countries or 
a group of countries is obtained by calculating 
the weighted average value of indices for 
individual countries (GLij). The weights of each 
of the countries in total turnover in specifi c 
goods or groups of goods are considered to be 
weights.
Intensity indicators for Poland’s intra-industry 
trade in pharmaceutical products with individual 
EU countries in 2004-2016 are presented in Tab. 1. 
They were calculated for three-digit groups of 
goods separated according to the Standard 
International Trade Classifi cation. The groups 
were: 541 – medicinal and pharmaceutical 
products (other than medicaments of group 
542) and 542 – medicaments (including 
veterinary medicaments). The presented data 
show that in the years 2004-2016 there was 
an increase in the intensity of intra-industry 
trade in pharmaceuticals with the majority of 
EU countries. The intra-industry trade with 
countries that were members of the Community 
before its enlargement in 2004 (EU-15) was 
particularly well developed.
The greatest increase in the intensity of 
intra-industry trade was recorded in trade with 
Denmark. In 2004, Polish-Danish intra-industry 
trade in pharmaceutical products practically 
did not exist, the Grubel-Lloyd index was only 
0.034. However, in the last year covered by 
the analysis, intra-industry trade was already 
the dominant form of trade with Denmark 
(GLDK = 0.883). A signifi cant increase in the 
intra-industry trade index was also recorded 
in trade with Portugal, Spain, and Italy (see 
Tab. 1). In the case of several trading partners, 
the two-way trade intensity indices decreased 
over the period considered. However, these 
countries did not belong to the group of 
Poland’s most important EU trade partners in 
pharmaceutical products. In 2016, their share 
in Poland’s trade in pharmaceutical products 
amounted only 6.2%, which did not signifi cantly 
affect the development of the aggregate 
Grubel-Lloyd index for pharmaceuticals, which 
increased from 0.125, in 2004 to 0.417, in 2016 
(see Fig. 1).
In order to identify the factors, which 
determine Poland’s intra-industry trade with 
European Union countries, an econometric 
model for panel data was constructed. The 
values of the bilateral Grubel-Lloyd index 
were assumed to be the explained variable. 
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Due to the fact that the explained variable 
takes values from the interval [0;1] the logit 
transformation of the explanatory variable GLjt 
has been performed. The dependent variable 
was obtained in the form of logit ln[GLjt/(1-GLjt)], 
whose values belong to the range (-;). 
Thus, the possibility of obtaining the theoretical 
values of the GLjt index that exceed the allowed 
range [0;1] was eliminated. The indices 
of intra-industry trade were calculated for 
Poland’s trade with individual EU countries, in 
the years 2004-2016, for three-digit product 
groups separated according to the Standard 
International Trade Classifi cation. These groups 
were: 541 – medicinal and pharmaceutical 
products (other than medicaments of group 
542) and 542 – medicaments (including 
veterinary medicaments). The study included 
27 Polish trade partners who were members 
of the European Union in 2016. In order not 
to eliminate countries for which no intra-
industry trade occurred in individual years, the 
procedure proposed by Lee and Lee (1993) 
was applied. It is based on the assumption that 
the explained variable (the Grubel-Lloyd index) 
instead of the value 0, takes a very small value 
equal to 0.0000001 and on substitution of this 
value for logarithmic purposes.
Country 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
Austria 0.004 0.010 0.234 0.139 0.154 0.277 0.255 0.204 0.200 0.109 0.086 0.123 0.128
Belgium 0.003 0.004 0.013 0.018 0.005 0.021 0.045 0.034 0.034 0.062 0.090 0.105 0.131
Bulgaria 0.636 0.174 0.095 0.281 0.108 0.183 0.270 0.603 0.786 0.949 0.850 0.883 0.674
Croatia 0.514 0.375 0.549 0.733 0.957 0.942 0.387 0.314 0.605 0.380 0.681 0.573 0.616
Cyprus 0.758 0.129 0.804 0.016 0.090 0.619 0.626 0.618 0.862 0.900 0.268 0.113 0.092
Czech Republic 0.717 0.616 0.519 0.628 0.672 0.792 0.597 0.620 0.550 0.578 0.606 0.588 0.700
Denmark 0.034 0.082 0.141 0.181 0.233 0.392 0.524 0.482 0.618 0.745 0.537 0.750 0.883
Estonia 0.228 0.148 0.071 0.181 0.015 0.004 0.047 0.011 0.012 0.003 0.005 0.010 0.008
Finland 0.952 0.300 0.329 0.247 0.661 0.929 0.680 0.796 0.371 0.312 0.337 0.447 0.515
France 0.049 0.040 0.059 0.151 0.237 0.311 0.369 0.369 0.593 0.536 0.602 0.573 0.386
Germany 0.164 0.130 0.218 0.338 0.369 0.462 0.525 0.535 0.546 0.566 0.473 0.417 0.489
Greece 0.046 0.020 0.532 0.762 0.858 0.763 0.871 0.837 0.809 0.635 0.466 0.234 0.182
Hungary 0.366 0.442 0.654 0.606 0.622 0.699 0.495 0.293 0.341 0.579 0.594 0.531 0.444
Ireland 0.000 0.001 0.006 0.074 0.102 0.100 0.114 0.118 0.162 0.092 0.090 0.110 0.065
Italy 0.239 0.160 0.269 0.439 0.490 0.733 0.839 0.840 0.779 0.796 0.793 0.854 0.832
Latvia 0.419 0.213 0.137 0.090 0.120 0.167 0.089 0.191 0.112 0.066 0.154 0.174 0.227
Lithuania 0.032 0.013 0.005 0.030 0.060 0.077 0.114 0.187 0.087 0.307 0.360 0.290 0.394
Luxembourg 0.005 0.000 0.000 0.001 0.000 0.000 0.003 0.000 0.005 0.001 0.010 0.061 0.128
Malta 0.000 0.062 0.217 0.036 0.073 0.285 0.272 0.158 0.284 0.372 0.136 0.081 0.109
Netherlands 0.017 0.028 0.018 0.026 0.067 0.046 0.081 0.107 0.136 0.183 0.156 0.123 0.097
Portugal 0.054 0.225 0.232 0.794 0.448 0.143 0189 0.293 0.364 0.398 0.565 0.680 0.772
Romania 0.793 0.858 0.642 0.648 0.431 0.574 0.589 0.641 0.715 0.890 0.889 0.876 0.672
Slovakia 0.341 0.741 0.902 0.841 0.632 0.627 0.456 0.473 0.714 0.651 0.293 0.298 0.269
Slovenia 0.025 0.117 0.132 0.113 0.169 0.281 0.217 0.375 0.325 0.302 0.334 0.324 0.329
Spain 0.058 0.113 0.194 0.376 0.541 0.776 0.715 0.763 0.613 0.825 0.452 0.385 0.717
Sweden 0.017 0.137 0.171 0.842 0.360 0.436 0.361 0.694 0.464 0.188 0.229 0.245 0.299
United Kingdom 0.092 0.105 0.208 0.359 0.334 0.393 0.432 0.464 0.441 0.448 0.652 0.651 0.603
Source: own calculations based on the Eurostat (2018)
Tab. 1: Intensity of intra-industry trade between Poland and European Union countries in pharmaceutical products in the years 2004-2016
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3. Theoretical Hypotheses
Based on theoretical literature and the results 
of previous empirical studies on country-
specifi c determinants of intra-industry trade, 
some research hypotheses (H1-H8) have 
been formulated below. They focus on the 
characteristics of the economies of countries 
that are Poland’s trading partners within the 
European Union. Due to the specifi city of goods 
being subject to exchange, which in this case 
are pharmaceutical products, it was decided to 
formulate one hypothesis more (i.e., H9). The 
hypothesis H9 is not directly derived from the 
theory of intra-industry trade, however, in the 
context of the considerations regarding trade 
in pharmaceuticals, it seems to be justifi ed. 
It concerns the category describing general 
government expenditure on health. It was 
assumed that this category of government 
spending signifi cantly infl uences the intensity of 
intra-industry trade in pharmaceutical products.
The following research hypotheses 
concerning the intensity of intra-industry trade 
in pharmaceutical products between Poland 
and EU countries have been verifi ed:
H1: The size of the economies of Poland’s 
trade partners, measured by the size of their 
GDP, has a positive effect on the intensity of 
intra-industry trade with these partners in 
pharmaceutical products.
H2: There is a negative relationship 
between the relative differences in the size of 
the Polish economy and its trading partners’ 
economies (measured by the size of GDP) 
and the intensity of intra-industry trade in 
pharmaceutical industry.
H3: The level of economic development 
of trade partners, measured by their GDP per 
capita, is positively correlated with the intensity 
of intra-industry trade with these partners in 
pharmaceutical products.
H4: There is a negative dependence 
between the relative differences in the level 
of economic development of Poland and its 
trading partners (measured by the size of GDP 
per capita) and the intensity of mutual intra-
industry trade in pharmaceutical products.
H5: The intensity of intra-industry trade 
in Poland’s bilateral trade in pharmaceutical 
products is positively correlated with the 
intensity of trade between the countries, 
measured by the share of the trading partner 
in Poland’s trade in pharmaceutical industry 
products.
H6: The level of imbalance in Poland’s 
bilateral trade in pharmaceutical products 
Fig. 1:
Intensity of intra-industry trade between Poland and European Union 
in pharmaceutical products in the years 2004-2016 calculated based 
on the Grubel-Lloyd aggregate index
Source: own calculations based on the Eurostat (2018)
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weakens the intensity of intra-industry trade in 
this kind of goods.
H7: There is a negative dependence 
between the geographical distance that 
separates trading partners and the intensity of 
their intra-industry trade.
H8: There is a positive dependence 
between the fact of having a common border 
with a trading partner and the intensity of intra-
industry trade in pharmaceutical products.
H9: The size of general government 
expenditure on health incurred in trade partner 
countries has a positive impact on the intensity 
of intra-industry trade in pharmaceutical 
products between these partners.
The research hypotheses allowed model 
specifi cation for panel data:
 
(3)
 (4)
The description of individual variables and 
the sources of data used are presented in 
Tab. 2.
4. Model Estimation
Estimation of the panel data model, defi ned 
by the formula (3), was made using the Gretl 
programme (GNU Regression Econometrics 
Time-Series Library version 9.1.14.). Both 
the occurrence and signifi cance of individual 
effects, as well as the nature of individual 
effects themselves (fi xed or random) were not 
assumed a priori. The choice of the estimation 
method (pooled OLS, fi xed effects, random 
effects) was made using the decision procedure 
proposed in the econometrics literature (see, 
among others Baltagi, 2001). Models with 
fi xed and random effects were assessed and 
diagnostic tests were carried out. The results 
of the diagnostic tests are presented in Tab. 3.
Based on the diagnostic tests carried 
out, it was found that an appropriate model 
for studying the impact of macroeconomic 
determinants on the intensity of intra-industry 
trade is the fi xed effects model (FE). Thus, 
the parameters of the fi xed effects model 
Variables Description of variables
GLjt
Intensity of intra-industry trade between Poland and the country j in the year t, 
measured by the Grubel-Lloyd index.
Data source: Eurostat (2018), code: DS-018995.
GDPjt
Gross Domestic Product of the partner country j, in the year t.
Data source: Eurostat (2018), code: nama_10_gdp.
DiffGDPjt
The index of the relative difference in the size of Poland’s GDP and the trading 
partner j, in the year t. The index values are determined by means of the following 
formula (Zhang & Li, 2006): 
, (5)
 
(6)
where:
GDPPLt, GDPjt – gross domestic product of Poland and its trading partner j in the 
year t.
The above index takes values from the interval [0;1]. If the differences in GDP 
between countries are large, then the index approaches the value of 1. With the 
same GDP of both countries, the value is 0.
Data source: Eurostat (2018), code: nama_10_gdp.
Tab. 2: The variables used in empirical investigation (Part 1)
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PCIjt
The variable representing the level of economic development of the trading partner j, 
in the year t, expressed as GDP per capita.
Data source: Eurostat (2018), code: nama_10_pc.
DiffPCIjt
The variable representing the distance in the level of economic development that 
divides Poland and its trading partner j, in the year t. The values of the index are 
measured using the following formula (Zhang & Li, 2006):
, (7)
 
(8)
where:
PCIPLt, PCIjt – GDP per capita of Poland and its trading partner j, in the year t.
The above index takes values from the interval [0;1]. If the differences in per capita 
income between countries are high, then the index approaches 1. With the same 
GDP per capita of both countries, the value is 0.
Data source: Eurostat (2018), code: nama_10_pc.
TIjt
The share of the country j in Poland’s trade in pharmaceutical products, in the year t.
Data source: Eurostat (2018), code: DS-018995.
TIMBjt
The degree of imbalance in trade between Poland and the country j, in the year t. 
The variable is determined according to the below formula:
, (9)
where:
Xjt –  Polish exports to the country j, in the year t,
Mjt – Polish imports to the country j, in the year t.
The TIMBjt variable takes the value of 0, if the trade between Poland and its trading 
partner, in the year t, is balanced (Xjt = Mjt) and takes the value of 1, if in one of the 
countries, its exports or imports (but not both exports and imports at the same time) 
is equal to 0. 
Data source: Eurostat (2018), code: DS-018995.
DISTj
Geographical distance, measured in kilometres, between the capital cities of Poland 
and its trading partner j. 
Data source: Centre D’Etudes Prospectives et D’Informations Internationales 
(2018). 
BORj
Dummy variable, takes the value of 1, if Poland has a common border with a trading 
partner j and the value of 0, if it does not border with the trading partner j.
HEALTHjt
General government expenditure on health incurred by the country of the trade 
partner j, in the year t.
Data source: Eurostat (2018), code: gov_10a_exp_COFOG_GF07.
vjt
Random error in the object j, in the time period t, which consists of the following 
components:
et – impulses affecting all observations in the period t,
uj – impulses affecting all observations in the object j,
εjt – impulses affecting only observations in the object j, in the period t.
Source: own
Tab. 2: The variables used in empirical investigation (Part 2)
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were estimated. However, a phenomenon of 
heteroscedasticity occurred, i.e. heterogeneity 
of variances of random components within 
the sample. Heteroscedasticity affects the 
incorrect estimation of standard errors for 
individual parameters and overestimation of 
the determination coeffi cient, which may distort 
the conclusions drawn on the signifi cance of 
variables. Therefore, ultimately, the Weighted 
Least Squares (WLS) method was used to 
estimate the parameters, where the weights 
were the inverse of the elements from the 
variance of random components estimated for 
individual units in the panel.
5. Results of Estimation 
and Discussion of Findings
Values of statistically signifi cant parameters 
of the model described by the formula (3) are 
presented in Tab. 4.
The model is correct in statistical terms. 
Five of the nine potential explanatory variables 
turned out to be signifi cant. The general 
performance of the model is satisfactory 
(Adjusted R2 = 0.693769).
When interpreting the results obtained, 
you can use the following interpretation 
method in relation to the variables that were 
previously logarithmized: an increase in the 
explanatory variable by 1% causes, ceteris 
Diagnostic test Test statistic p-value
Wald test F = 8.46793 < 0.00001
Breusch-Pagan test LM = 156.423 < 0.00001
Hausman test H = 25.3214 < 0.00001
Source: own calculation
Tab. 3: Test statistics and signifi cance levels in the diagnostic tests of the model of intra-industry trade in pharmaceuticals between Poland and EU countries
Dependent variable 
ln[GLjt/(1-GLjt)]
Independent 
variables Coeffi cient Std. Error t-ratio p-value Signifi cance
Constant 2.9795100 1.0755700 2.770 0.00590 ***
PCIjt -0.6340501 0.1238950 -5.118 <0.00001 ***
DiffPCIjt -0.0359025 0.0158606 -2.264 0.02420 **
TIjt 0.1717640 0.0534901 3.211 0.00140 ***
TIMBjt -1.7156300 0.0751459 -22.830 <0.00001 ***
HEALTHjt 0.2079440 0.0562981 3.694 0.00030 ***
Observations 351
Standard error of residuals 0.902791
R2 0.698143
Adjusted R2 0.693769
F (5, 345) = 159.5853 p-value for test F < 0.00001
Source: own calculations
Note: ** Statistically signifi cant at 5%, *** signifi cant at 1%
Tab. 4: The results of estimation of the model describing the determinants of intra-industry trade in pharmaceuticals
EM_2_2019.indd   196 19.6.2019   15:11:30
1972, XXII, 2019
Marketing and Trade
paribus, an increase or decrease (depending 
on the sign of the parameter) of the explained 
variable by α% (a parameter located at a given 
variable explanatory). In this case, the logit is 
the explained variable, which means that the 
relation GLjt/(1-GLjt), which is the index of intra-
industry trade (GLjt) and inter-industry trade 
(1-GLjt) changes by α%.
The size of GDP per capita achieved in 
the countries of Poland’s trading partners 
turned out to be a variable that signifi cantly 
and negatively impacts the intensity of intra-
industry trade. This variable represents the 
level of economic development of individual 
countries. The research carried out shows that, 
on average, GDP growth per capita in trading 
partners’ countries by 1% causes a decrease 
that is less than proportional (by about 0.6%) 
in the ratio of intra-industry to inter-industry 
trade in pharmaceutical products. The results 
obtained with regard to this variable – this is 
the direction of the impact, do not confi rm the 
predictions of the theory of intra-industry trade, 
according to which higher per capita income 
facilitates intense intra-industry exchange (see 
hypothesis H3). Therefore, it is worth making 
an attempt to explain this relationship in the 
context of trade in pharmaceutical products.
In the theory of intra-industry trade, the 
impact of the GDP per capita variable on the 
intensity of intra-industry trade is considered on 
the demand and supply side (Czarny, 2002). In 
the fi rst case, it is indicated that along with the 
increase in consumer incomes, their willingness 
to purchase differentiated products increases, 
they often buy many variants of varied goods or 
are willing to pay more for the preferred option, 
best suited to their expectations. This behaviour 
of consumers, i.e., the demand for goods 
differentiated at the aggregate level, facilitates 
the development of intra-industry trade. It is 
worth noting, however, that pharmaceutical 
products are specifi c goods purchased by 
consumers in strictly defi ned situations resulting 
from the needs of protecting their health or 
even lives.
Therefore, in this particular situation, the 
result obtained (the negative impact of the 
PCIjt variable on the intensity of intra-industry 
turnover of pharmaceutical products) may 
be justifi ed. In the case of pharmaceutical 
products, taking (consuming) by the fi nal 
consumer (patient) many variants of a particular 
good (pharmaceutical products) is unjustifi ed 
and even harmful from a medical point of view. 
Thus, customers (patients) generally do not 
report additional demand for further variants 
of the pharmaceutical product along with an 
increase in income. An exception in this case 
may be pharmaceutical products being dietary 
supplements.
The negative impact of the PCIjt variable can 
also be explained by analysing the phenomenon 
from the supply side. Interpretation then refers 
to the resources of production factors in trading 
countries. Rich countries with a signifi cant GDP 
per capita have large capital resources, which 
allows the development of high technology 
industries, which undoubtedly include the 
pharmaceutical industry. A country’s well-
developed pharmaceutical industry produces, 
apart from relatively simple preparations, also 
the most modern drugs. It is therefore possible 
to develop exports, especially of technologically 
advanced drugs, to countries that do not 
produce them. Therefore, less affl uent countries 
can offer simple, less technologically advanced 
drugs on the market, which can be produced 
without the need to possess or buy licenses, so 
these are more often generic drugs. However, 
it should be noted that these drugs, i.e. simple 
ones, are also produced by the pharmaceutical 
industry in richer countries, sometimes even 
cheaper due to the disclosure of the economies 
of scale. Therefore, there is no need to import 
them from other countries, and this certainly 
is not conducive to the development of intra-
industry trade.
The confi rmation of the above reasoning 
may be the results obtained with respect to the 
DiffPCIjt variable. The research fi ndings show 
that in trade in pharmaceutical products, the 
relative differences in the level of economic 
development of Poland and its trading partners 
limit the development of mutual intra-industry 
trade. The parameter α at the DiffPCIjt variable 
was -0.0359025. Thus, the hypothesis H4 was 
positively verifi ed.
The results of the study confi rm that the 
factor that signifi cantly and also positively 
affects the growth of intra-industry trade indices 
is the degree of trade intensity between Poland 
and its trading partners (the TIjt variable). The 
intensity of trade was expressed in the share of 
individual trade partners in Poland’s total trade 
in pharmaceutical products. The obtained value 
of the parameter α at the variable TIjt informs 
that, on average, the increase in the intensity 
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of trade between countries by 1% results in an 
increase of intra-industry trade in relation to 
inter-industry trade by over 0.17%. Therefore, 
the research hypothesis H5 was positively 
verifi ed.
The factor that signifi cantly but at the 
same time negatively impacts the intensity of 
intra-industry trade is the degree of imbalance 
in trade between pharmaceutical products 
between Poland and the European Union. 
A signifi cant impact of this variable was to be 
expected because in a situation when trade 
between two countries is not balanced, the 
Grubel-Lloyd index cannot reach the maximum 
value. The parameter α at the TIMBjt variable 
was -1.71563. The hypothesis H6 was positively 
verifi ed.
General government expenditure on health in 
the country of the trade partner was a statistically 
signifi cant factor infl uencing the intensity of intra-
industry trade in Poland’s trade in pharmaceutical 
products. This variable was included in the 
model deliberately, due to the specifi cs of the 
analysed goods. Pharmaceutical products serve 
to protect health and life. The study confi rms that 
increasing government expenditure on health in 
the trade partner country has a positive impact 
on the intensity of intra-industry trade with this 
country (α = 0.207944). With reference to the 
variable HEALTHjt, the sign which was obtained 
was consistent with the assumption made in the 
hypothesis H9, which allowed for its positive 
verifi cation. 
The variables related to the size of the 
economies of trade partners (GDPjt and 
DiffGDPjt) were proved to be statistically 
insignifi cant. Therefore, the H1 hypothesis, 
according to which intra-industry trade is 
more intense in trade with large countries that 
have a larger GDP, could not be verifi ed. The 
H2 hypothesis, according to which the larger 
relative differences in the size of economies 
– of Poland and its trading partners, the 
less intense intra-industry exchange, could 
not be verifi ed, either. The DISTj and BORj 
variables were also statistically insignifi cant. 
This means that the H7 hypothesis, which 
assumed a negative dependence between the 
geographical distance that separates trading 
partners and the intensity of their intra-industry 
exchange, and the H8 hypothesis, according to 
which the intra-industry trade develops better 
if the countries are close neighbours, i.e. they 
have a common border, were not verifi ed.
Conclusions
One of the manifestations of the ongoing 
cooperation of countries is the intensifi cation 
of mutual intra-industry trade understood 
as parallel import and export of similar 
products belonging to the same industry 
(commodity group). This paper identifi ed the 
factors determining intra-industry trade in 
pharmaceutical products between Poland and 
European Union countries. The focus is on 
factors that relate to the characteristics of the 
trading partner economies, i.e. the so-called 
country-specifi c determinants. In the case 
of pharmaceutical products, the factors that 
related to the level of economic development 
of trading partners were statistically signifi cant. 
However, the research shows that the level of 
economic development of EU member states 
(measured by the size of their GDP per capita) 
is not conducive to the development of intra-
industry trade. The direction of the infl uence 
of this variable on the development of intra-
industry trade obtained in this study does not 
confi rm the predictions of the theory of intra-
industry trade. However, the negative impact of 
this factor can be explained by the specifi city 
of pharmaceutical products. These products 
do not belong to the category of goods for which 
customers report greater demand when their 
revenue increases. Since it is not medically 
justifi able, they do not want to buy many 
variants of specifi c pharmaceutical products, as 
it usually happens in the case of other goods, 
e.g. in the case of clothing.
The impact of the variable describing the 
relative differences in the level of economic 
development of Poland and its trading partners 
on the intensity of mutual intra-industry trade 
is in contrast with the predictions of the theory. 
The research shows that the degree of the 
intensity of trade in pharmaceutical products 
between Poland and its trading partners also 
has an important and positive impact on the 
development of intra-industry trade. On the 
other hand, however, the degree of imbalance 
in trade in pharmaceutical products between 
Poland and EU countries has a negative impact. 
The obtained results of the research also 
confi rm that an important factor that positively 
infl uences the development of intra-industry 
trade in pharmaceutical products is the size of 
general government expenditure on health in 
the country of the trade partner.The variables 
related to the size of the trading partners’ 
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economies, the geographical distance between 
Poland and its trading partners, and the fact 
that Poland has a common border with some 
trade partners turned out to be statistically non-
signifi cant factors.
The model of intra-industry trade 
constructed in this study can be used to identify 
countries (within the European Union) which 
have potential for the development of trade 
in the fi eld of pharmaceutical products. In this 
context, particular attention should be paid 
to those trading partners with whom trade in 
pharmaceuticals is relatively large and intra-
trade indicators remain at a low level.
This study is part of the research stream 
that has been undertaken in world science. 
However, it certainly does not exhaust the 
problem. In terms of the presented issue, it 
is worth examining the impact of identifi ed 
determinants separately on vertical intra-
industry trade and separately on horizontal 
intra-industry trade. Particularly interesting in 
this context could also be in-depth analyses of 
the impact of foreign direct investment (broken 
down into the vertical and horizontal forms) on 
intra-industry trade.
The paper was supported by the 
research project “Positive social change in 
an organization as a factor of a company 
engagement in sustainable development”. The 
project was funded by the National Science 
Centre, Poland, on the decision number DEC-
2017/25/B/HS4/01113.
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Abstract
COUNTRY-SPECIFIC DETERMINANTS OF INTRA-INDUSTRY TRADE IN 
PHARMACEUTICALS: THE CASE OF POLAND AND ITS EUROPEAN UNION 
PARTNERS
Justyna Łapińska, Jana Meluzínová, Jiří Uhman
Trade cooperation between European Union countries is based mainly on intra-industry trade, 
consisting in the simultaneous import and export of similar products belonging to the same industry 
(commodity group). 
The present study has investigated the country-specifi c determinants of intra-industry trade 
between Poland and its European Union trading partners in pharmaceutical products during the 
time period 2004-2016. To this end, an econometric model for panel data was constructed.
The research shows that the intensity of intra-industry trade in Poland-EU trade in pharmaceuticals 
is determined by several key factors. The intensity of trade with particular EU countries and the size 
of general government expenditure on health in the countries of trading partners have a positive 
impact on the development of this type of exchange. A factor that signifi cantly and simultaneously 
affects the intensity of intra-industry trade is the degree of imbalance in the trade balance in 
pharmaceutical products with individual trading partners.
The development of intra-industry trade is also limited by factors related to the level of economic 
development of trading partners. The study confi rmed that the greater the differences in the level of 
GDP per capita between Poland and the trading partner, the less intense intra-industry trade. Also, 
the growth of GDP per capita in the countries of trade partners is not conducive to the development 
of intra-industry trade in Poland’s trade in pharmaceuticals. The direction of the impact of this 
variable (GDP per capita) on the intensity of two-way trade obtained in this study does not confi rm 
the predictions of the theory of intra-industry trade. However, the negative impact of this factor 
can be explained by the specifi city of pharmaceutical products that are purchased by consumers 
generally only in justifi ed situations resulting from health or life protection.
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